Re: patent extensions,,,,not likely.... thanks guys..
in response to
by
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: turning into a bad investment
Well pharmas 
when a drug is about to come off patent, will purify out non-active isomers.. 'new' drug.. another one they really like is to combine two already off patent drugs to make a 'new' drug they can charge more for..
You're right.. hard to do with a RO..
New Message
Please
login
to post a reply